Sign Up for E-mail Updates

Office Closure logo

Health and Human Services Commission


Pharmaceutical and Therapeutics Committee

Sept. 20, 2013
9 a.m.

Meeting Site:
Health and Human Services Commission
Brown-Heatly Building
Public Hearing Room
4900 North Lamar Blvd.

  1. Call to Order.
  2. Approval of Minutes from Aug. 16, 2013.
  3. New Business: Public Comment on Drug Classes to be reviewed for the Medicaid Preferred Drug List (PDL) (Drug Classes Listed Below):
    1. Cytokine and Cell-Adhesion Molecules Antagonists
    2. Growth Hormone
    3. Hypoglycemics, Incretin Enhancers/Mimetics
  4. Therapeutic and Clinical Drug Reviews and Updates:  Chris Andrews, Pharm.D., Magellan Medicaid Administration.
  5. Executive Work Session.
    Pursuant to Texas Government Code, Chapter 531, and in accordance with Title 1,Texas Administrative Code, Part 15, Subchapter F, §354.1928, the Pharmaceutical and Therapeutics Committee may meet in Executive Session on one or more items listed under New Business.
  6. Announcements of Drugs Recommended for the Medicaid PDL.
  7. Adjourn.
  8. Next Meeting Date: Nov. 22, 2013.

Contact:  Julie Nieto, Health and Human Services Commission Medicaid/Children’s Health Insurance Program Division at 512-707-6134,

This meeting is open to the public.  No reservations are required and there is no cost to attend this meeting.

People with disabilities who wish to attend the meeting and require auxiliary aids or services should contact Nieto at 512-707-6134 at least 72 hours before the meeting so appropriate arrangements can be made.


A quorum may be achieved by telephonic attendance in the event that a board member or board members are unable to attend the meeting in person.